(redirected from 5-fluorouracil)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.
5-FU5-Fluorouracil (drug used against pancreatic cancer)
References in periodicals archive ?
Editor's Note: When grape seed was administered with 5-fluorouracil to cultured human colon cancer cells, the drug's ability to inhibit cancer growth was boosted by 26% in comparison to drug treatment alone.
Pharmacokinetically (PK) guided dose adjustment of 5-fluorouracil (5-FU): a rational approach to improving therapeutic outcomes.
Flow cytometry results indicated that the combination of eugenol and 5-fluorouracil increased the number of cells in the S and G2/M phases when compared to treatment with the individual compounds alone.
Cardiotoxicity of 5-fluorouracil in combination with folinic acid in patients with gastrointestinal cancer.
We present a 57-year-old black female with Dukes C colon carcinoma who, despite receiving a right hemicolectomy at the time of initial diagnosis, developed neutropenic enterocolitis after tr eatment with 5-fluorouracil and leucovorin.
A potent anticancer agent, 5-fluorouracil is used in combination with other drugs to treat ovarian and breast cancer.
In 1989, he led a study showing that a combination of 5-fluorouracil and another drug, called levamisole, decreased by one-third the risk of dying from colon cancer recurrence (SN: 10/7/89, p.
The FDA Approved FUSILEV For Use In Combination Chemotherapy With 5-Fluorouracil In The Palliative Treatment Of Patients With Advanced Metastatic Colorectal Cancer On April 29, 2011
An article published in PLOS One reports the finding of a chemosensitizing benefit for curcumin, a compound occurring in turmeric, in colon cancer cells resistant to treatment with the chemotherapy drug 5-fluorouracil (5-FU).
will serve as exclusive distributor of Saladax's My5-FU[TM] diagnostic test, which measures levels of a widely-used anti-cancer drug, 5-fluorouracil (5-FU), in the blood of cancer patients, in Egypt and throughout the Middle East North African (MENA) region.
Since the antiproliferative action of micromolar bisabololoxide A on cancerous cells was expected to be beneficial to cancer treatment, the modification of antiproliferative action of 5-fluorouracil (3-30 [micro]M) by bisabololoxide A was studied.